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Abstract
Background: Retinitis pigmentosa is characterized by the sequential loss of rod and cone photoreceptors. The
preservation of cones would prevent blindness due to their essential role in human vision. Rod-derived Cone
Viability Factor is a thioredoxin-like protein that is secreted by rods and is involved in cone survival. To validate the
activity of Rod-derived Cone Viability Factors (RdCVFs) as therapeutic agents for treating retinitis Pigmentosa, we
have developed e-conome, an automated cell counting platform for retinal flat mounts of rodent models of cone
degeneration. This automated quantification method allows for faster data analysis thereby accelerating
translational research.
Methods: An inverted fluorescent microscope, motorized and coupled to a CCD camera records images of cones
labeled with fluorescent peanut agglutinin lectin on flat-mounted retinas. In an average of 300 fields per retina,
nine Z-planes at magnification X40 are acquired after two-stage autofocus individually for each field. The projection
of the stack of 9 images is subject to a threshold, filtered to exclude aberrant images based on preset variables.
The cones are identified by treating the resulting image using 13 variables empirically determined. The cone
density is calculated over the 300 fields.
Results: The method was validated by comparison to the conventional stereological counting. The decrease in
cone density in rd1 mouse was found to be equivalent to the decrease determined by stereological counting. We
also studied the spatiotemporal pattern of the degeneration of cones in the rd1 mouse and show that while the
reduction in cone density starts in the central part of the retina, cone degeneration progresses at the same speed
over the whole retinal surface. We finally show that for mice with an inactivation of the Nucleoredoxin-like genes
Nxnl1 or Nxnl2 encoding RdCVFs, the loss of cones is more pronounced in the ventral retina.
Conclusion: The automated platform ℮-conome used here for retinal disease is a tool that can broadly accelerate
translational research for neurodegenerative diseases.
Background
Retinitis pigmentosa (RP) is characterized clinically by an
initial loss of night vision resulting from the degeneration
of rod photoreceptors directly due to a genetic deficit, fol-
lowed irreparably over a period of several years by the loss
of central vision that results from the non-cell autono-
mous death of cone photoreceptors [1]. Because cones
dominate the centre of the retina and are responsible for
the high-acuity and color vision, their preservation would
be medically relevant as a ther a p ya i m e da tp r e v e n t i n g
blindness [2]. We have studied the mechanisms involved
in the secondary degeneration of cone photoreceptors in
the rd1 mouse model of recessive RP, which carries a
mutation in the rod photoreceptor-specific cGMP phos-
phodiesterase b-subunit gene [3]. Initially, we showed that
grafting normal photoreceptors (97% of rods) into the eyes
of this rod-less model, before the degeneration of cones,
exerts a protective effect on cones [4]. We subsequently
demonstrated that the neuroprotective activity was
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any medium, provided the original work is properly cited.mediated by protein(s) secreted by rods [5,6]. One of these
proteins, Rod-derived Cone Viability factors (RdCVF)
whose expression is rod-dependent, was then identified by
screening a retinal cDNA library in an assay based on the
viability of cone-enriched cell culture cells made from
chicken embryos [4]. The viability of these cells was moni-
tored by fluorogenic probes for more than 200,000 cul-
tures in a 96 wells format using a platform developed for
this high content screening. RdCVF protein, when injected
into the subretinal space of a rodent model of retinal
degeneration prevents the loss of function of cone photo-
receptors [4,7]. Interestingly, RdCVF is encoded by the
Nucleoredoxin-like gene, Nxnl1 that belongs to the family
of thioredoxin proteins, reducing oxidative stress, a condi-
tion encountered broadly in neurodegenerative diseases
[8]. This novel trophic signaling is part of an endogenous
defense response since cone photoreceptors degenerate
during aging in the Nxnl1-/- mouse and at an accelerated
rate in the presence of high levels of oxygen [9]. We have
also identified Nxnl2, a paralogue gene that also encodes a
cone survival factor, RdCVF2 [10]. The administration of
RdCVF in patients suffering from RP at early stage of the
disease could therefore reduce secondary cone degenera-
tion and prolong central vision.
Whatever the delivery system used–be it protein injec-
tion, viral vector delivery or even by reactivation of the
RdCVF promoter in neighboring cells [7,11,12] –this
translational research program requires the development
of a robust system to test the trophic activity toward
cones of the therapeutic molecules produced for human
clinical trial. The technical difficulties in measuring accu-
rately the cone density as noticed by LaVail et al., [13]
were solved using stereological counting [5]. We report
here the development of ℮-conome, a fully automated
platform for measuring cone density in mouse models of
cone degeneration. We demonstrated the reliability of
this platform by comparing the kinetics of cone degen-
e r a t i o ni nt h erd1 retina measured using our platform to
that measured by standard stereological counting. In par-
allel, we developed an automated, operator-independent
stereological method that was also evaluated for accu-
racy. The automated platform scanned the whole surface
of the flat-mounted retina allowing the user to evaluate
the local density of cones as demonstrated by the pattern
of S-cones in the rd7 retina. We studied the spatiotem-
poral pattern of cone loss in the rd1 retina as well as the
loss of cones in the nucleoredoxin-like gene knock-out
mice Nxnl1-/- and Nxnl2-/-, revealing a more pro-
nounced loss in the ventral region of the retina. The
development of the platform ℮-conome, as validated in
the experiments reported here, will accelerate the transla-
tional research required to evaluate RdCVF as a thera-
peutic agent for cone degeneration in RP.
Methods
Animals
All procedures were in compliance with the Association
for Research in Vision and Ophthalmology Statement for
the use of Animals. The protocols approved by the
National Eye Institute Animal Care and Use Committee.
Animals, mixed gender were housed under a 12 hours
light/12 hours dark cycle and given ad-libitum access to
food and water. The two congenic C3H lines [14]
(C3Hrd1/rd1 and C3Hwt/wt) were re-derived and main-
tained at Charles River. The rd7 colony was obtained from
Jackson Laboratories, (USA). The homozygous knockout
mice Nxnl1 and their controls are described in [9]. The
Nxnl2 line is described in Jaillard et al. (manuscript in pre-
paration). All three lines have a pure BALB/c background.
Day of birth was designated postnatal day 0 (PN0).
Tissue collection
Retinal tissues were obtained from C3Hwt/wt and
C3Hrd1/rd1 eyes aged PN15 to 90 days. All the right eyes
of each genotype (n = 7) per age (PN15, 35, 43, 60 and 90
days) were analyzed by automated counting and the left
eyes by stereological counting. We then replicated the
experiment by inverting eye polarity. Animals were sacri-
ficed by decapitation. The orientation of the eyes was
marked on the limbus at 12 O’Clock position before enu-
cleating. Neural retinas were dissected in phosphate-buf-
fered saline (PBS) at room temperature from the posterior
eyecup followed by immersion in cold 4% paraformalde-
hyde (PFA) in PBS at pH 7.4. For cryosectioning, eyes
were fixed in cold PFA 4% in PBS overnight after punctur-
ing the cornea then left 1 hour in 10%, 11/2 hour in 20%
and 3 hours in 30% sucrose then quickly embedded in 4%
gelatin with liquid nitrogen. The section plane was
extended along the vertical axis from the optic nerve head
in the posterior retina to the cornea.
Production of polyclonal antibodies against S-Opsin
A peptide corresponding to the second extracellular loop
of mouse short wave opsin (CGPDWYTVGTKYRSE) was
synthesized and coupled to ovalbumin and injected into
two New-Zealand rabbits. The specificity of the polyclonal
antibodies was confirmed by immunohistochemistry and
compared with the pre-immune serum on rd7 retina (not
shown).
Immunohistochemistry on flat-mounted retina
Fixed retinas were rinsed with PBS three times, before
permeabilization (30 seconds for all genotypes and 5
minutes for C3Hrd1/rd1) in PBS containing 0.1% Triton
X-100, followed by incubation 1 hour in blocking buffer
PBS containing 1% of bovine serum albumin (BSA),
0.1% Tween-20 and 10% normal goat serum (NGS).
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Page 2 of 15After washing, retinas were labeled for 3 hours at room
temperature or overnight at 4°C with Alexa Fluor 594-
c o u p l e dp e a n u ta g g l u t i n i nl e c t i nf r o ma r a c h i sh y p o g a e
(PNA) [15] (1:40, Invitrogen, USA). For S-Opsin, the
retinas were incubated with anti-S-Opsin (1:400)
4 hours at 37°C followed by incubation overnight at 4°C
i nt h es a m eb l o c k i n gb u f f e r .T h er e t i n a sw e r ew a s h e d
six times with blocking buffer without NGS and incu-
bated with secondary antibody, goat anti-rabbit IgG con-
jugated to Alexa Fluor 488 (1:400, Invitrogen, USA). We
then performed four incisions of the whole retina to
obtain flat-mounted retina with the photoreceptor layer
facing up. Four retinas were placed on a vertical line.
For automated acquisition, the first and fourth retinas
w e r ek e p ta tad i s t a n c eo f5m mf r o mt h eu p p e ra n d
lower edges of the slide respectively.
Immunohistochemistry on frozen eye sections
Ten μm thick frozen eye sections were dried at room tem-
perature for immunohistochemistry as previously
described [9] with few modifications. No permeability was
applied and PNA was added for 3 hours at room tempera-
ture in the blocking buffer before immerging slides into
blocking buffer with Dulbecco’sM o d i f i e dE a g l eM e d i u m
(DMEM), 4.5 g/l of glucose, 10% of NGS and 10% of fetal
calf serum, 1 hour at room temperature followed by
S-Opsin incubation in the same buffer during 3 hours at
room temperature. After washing, the nuclear marker 4’-
6-diamidino-2-phenylindole (1:1000, DAPI, Sigma) was
added with the secondary antibody. Finally the sections
were mounted on glass slides with fade-resistant mounting
media (Biomeda, Forster city, CA) topped with coverslip
and imaged with a fluorescent microscope (Leica, USA).
Automated image acquisition of labeled cones on flat-
mounted retina
An inverse microscope (Nikon, Eclipse TE200, and 2000)
was equipped with a mercury super high pressure lamp, a
computer driven motorized stage (Multicontrol 2000,
Martzauzer, Wetzlar), an optical filter switch (Lambda 10-
2, Shutter Instrument company) for two excitation filters
(485 and 520 nm) and two emission filters (520 and 635
nm), a shutter driver (JML Direct Optics), two objectives
4X (0.10, infini/- , WD 30) and 40X (Plan Fluor 40X/0.75
Dic M, infini/0.17, WD 0.72), and a CCD camera (Cool-
SNAP FX and HQ, Photometrics). The pieces of equip-
ment were connected (Figure 1) and controlled by
algorithm (Additional file 1) developed with Metamorph
(Universal Imaging Corporation, Sunnyvale, CA, USA). A
maximum of 5 slides with 4 flat-mounted retinas were
placed on the motorized stage platform and the position
of the centre of the retina were set-up manually using a
4X objective to record the coordinates (X, Y). The objec-
tive was switched to 40X and the platform stage moves
back to the first retina and the focus manually set-up on
labeled cones and recorded (Z). The program offers two
options for acquisition: the entire retina (grid) or a
draughtboard grid. The acquisition grid was designed
from nine assembled images (4X objective) and used for
the acquisition (X40 objective) of ~300 fields (Figure 1) of
identical surface area (0.0376 mm
2), covering the entire
surface of the retina (CoolSNAP FX: 217.75 × 172.53 μm,
CoolSNAP HQ: 224.46 × 167.70 μm). Two incremented
stages of autofocus were executed to recover the focal
plane for each individual plane (~300) on the overall ret-
inal surface. The first stage scans six different planes
within the depth of the retina with an increment of 60 μm
approaching the focal plane. The second stage is a fine
adjustment from this position using 8 planes with a lower
increment of 15 μm. Centered on this focal position, a
stack of nine images per field distanced by 0.7 μmw e r e
acquired in the Z-direction (Figure 1). All the stacks were
registered in Tagged Image File Format (TIFF) in a file
named by the date of the day followed by an increment
numbers. All images had a resolution of 650 × 515 pixels
in 16-bits images (1.72 Gigabytes for the entire retina).
Global automated cone quantification
The stacks of images were treated with an algorithm
using Metamorph to quantify cones (Additional file 1). A
projection though the nine plans of each file was applied
in order to reveal best focus plane to which was applied
an auto-threshold to reduce the background. The algo-
rithm is not perturbed by the overall orientation and
twist of the cones due to the use of a morphological filter.
In addition, the projection through the 9 planes that is
operated before counting is creating a virtual image in
which the cones are preferentially seen as a transversal
section though the cell body. This threshold was used to
detect dark areas resulting from retina pigmented epithe-
lium residue and to exclude the images that do not fulfill
the preset criteria. When this phenomenon is predomi-
nant, the field is excluded using the function dark_max
(Additional file 1b, line 11 in Editor\variables). The
image resulting from one field is segmented and the
threshold is applied locally to overcome difference in
brightness within an image (Additional file 1b, line 12-14
in FINDSPOT\3D Measurements). An adjustment of
digital contrast was operated to discriminate cells among
the cluster from background. At this stage eleven ordered
variables empirically determined were called [best focus
average intensity, autothreshold area %, number of cells
detected on best focus before treatment, minimal inten-
sity, number of minimal cells, max background, cluster,
dark max, spot cut-off, spot size, spot surface, Additional
file 1] to filter the images to be counted. The variables
are: lane 1) Best Focus average intensity, average intensity
of the projection of the nine images; 2) Percentage Best
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Page 3 of 15Figure 1 ℮-CONOME, the automated microscopy platform. (a) Connections between the different pieces of equipment. The motorized
stage is made for five slides with a maximum of four retinas per slide. (b) Visualization of the grid used for acquisition and counting (left).
Representative image of an acquisition for one field and the nine Z-planes (centre), the illustration corresponds to the best focus Z = 0 as
indicated. Schematic representation of the results of global automated counting in an Excel sheet (right). The color code is providing an easy
visualization of the fields of the grid during acquisition.
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Page 4 of 15Focus. Threshold autothreshold area percentage, percen-
tage of cells within the projected image over the thresh-
old; 3) Number of cells detected with Best Focus before
treatment, before the treatment with the algorithm find-
pot 4) Spotcutoff, the cutoff that is used to exclude
objects with aberrant measures; 5) Spotsize, the size
above which objects are excluded; 6) SurfSpot, the sur-
face above which objects are excluded; 7) IntMin, the
minimal intensity for an object to be retained; 8) NBOb-
jectsMin, the minimal number of objects that should
contain a projected image; 9) FondMax, the maximal
intensity of the total space between the objects; 10) Clus-
ter, The size of an object that is rejected since it is con-
sidered as a cluster of cells; 11) Dark_max, the minimal
intensity of a projected image. The values above the
threshold were arbitrarily equaled to zero in order to
enhance the contrast. The function find-spot was used
on each image filtered with the eight fits variables, to dis-
sociate neighboring cells and by calling three variables:
the spot cut-off, the spot size and the spot surface result-
ing in an accurate counting (Additional file 2). Finally,
the number of counted cells in the selected image was
mentioned with all parameters described above before
closing it. The density of cones are locally associated with
their coordinates (Figure 1), and used to calculate the
density of cones over the surface of the retina after hav-
ing removed the excluded fields.
Stereological cone Quantification
The stereological counting was achieved as described pre-
viously [5,7]. Briefly, the cones were counted on 50-80,
non-overlapping, 1,225 μm
2 fields selected with a systema-
tic random sampling procedure applied to the retinal sur-
face from the centre of the optic nerve head over a radius
of 2 mm.
Stereological automated cone quantification
The process was adapted from [5]. The area comprising
the optic nerve is indicated by the operator for its exclu-
sion. The number of fields was reduced from the global
method by using a draughtboard grid. Within each field, a
frame (30 μm×3 0μm) was drawn with exclusion of
object in contact with one of both axes X and Y. Within
these fields, the cones were counted with the parameters
used for the global methods. The results are expressed as
the average cone density over the counted fields.
Spatial distribution
The spatial distribution of cones was inferred from the
local densities with their coordinates X, Y recorded in an
Excel file and the orientation( V e n t r o - D o r s a l ,N a s o -
Temporal). A virtual eye fundus representation was
designed to visualize the data. The value X and Y were
used to calculate the position of the optic nerve and the
local density of cones in 9 rows taken from this centre are
projected on the disk annulus by annulus. To represent
the amount of cones in each segment, a color scale was
applied using multiples of 45 (45, 90,......,405).
Statistical Analysis
Statistical analyses were performed with GraphPad
Prism5.0, with p < 0.05 considered significant. Unpaired
Student’s t-test was used to compare density of cones
levels in rd1 at different ages with a Welch’sc o r r e c t i o n .I n
figure 4, we compared the value between three groups, by
a two-way anova where one factor stands for the days and
the second for the technique. For the normalized test
using the quantile-quantile normalization [16], the quan-
tiles of the set of measures obtained by each technique are
identical. To apply this normalization while avoiding any
bias due to overrepresentation of some dataset, curves
have been made first comparable by resizing each set in
such a manner that for a dataset the number of measure-
ments is equal using each method. As this can be done in
several ways by taking out 4 values, (one for PN60 for glo-
bal automated method, one for PN60 and for PN90 for
stereological method and one for PN35 for automated
stereological method), all 2,353 possible combinations
were tested. For each combination the two-way Anova led
to a p-value of one after normalization indicating that the
there is no difference between the three methods. To test
for cone regionalization in figures 7C and 7E, a paired t-
test was used to compare the means cone density (PNA)
from the same retina of the dorsal and ventral region for
Nxnl+/+ (n = 10), Nxnl1-/- (n = 7) and Nxnl2-/- (n = 8)
mouse. To compare the means S-cone density (S-opsin)
from the same retina of the dorsal and ventral region for
Nxnl+/+ (n = 5) and Nxnl2-/- (n = 5) mouse.
Results
Development and validation of the automated counting
platform
An inverted fluorescent microscope, motorized and
coupled to a CCD camera was designed to automatically
record images and count cones labeled with fluorescent
peanut agglutinin lectin (PNA) [15] on flat-mounted reti-
nas (Figure 1). In an average of 300 fields per retina, nine
Z-planes at magnification X40 and separated from each
other by 0.7 μm were acquired after two-stage autofocus
individually for each field, and covering the entire thick-
ness of outer retina. The stack of 9 images (650 × 515 pix-
els) was used to create a projection that was subject to a
threshold, filtered to exclude aberrant images (based on
preset variables) and contrast adjusted. The cones were
identified by treating the resulting image using 13 variables
empirically determined (see Methods). The cone density
was calculated over the ~300 fields, and averaged over the
counted fields. This method was compared to a non-
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dated the platform by studying the kinetics of secondary
cone degeneration in the rd1 mouse model [17]. For both
the rd1 (C3Hrd1/rd1) and wild-type (C3Hwt/wt) main-
tained on identical genetic background [14], the right eyes
(n = 7) at post-natal days (PN) 15, 35, 43, 60 and 90, were
analyzed with the novel automated counting method and
the left eyes used for stereological counting [5]. The eyes
were marked at the 12 O’Clock position before removing
the neural retina in order to preserve the orientation. The
decrease in cone density from PN15 to 90 was thus calcu-
lated from the PNA-labeled (both S- and M-cones) flat-
mounted rd1 retinas (Figure 2a). PNA labels the extracel-
lular sheaths around their outer segments and conse-
quently is an indirect measurement of cones. It is
nevertheless extensively used. As expected, no differences
in cone density were found for the wild-type (wt) mouse
using either methods (Figure 2b, 2c and Additional file 3).
At PN15 the values for wt and rd1 are not statistically dif-
ferent even if the remaining rods at this age might inter-
fere with the automated counting of cones. When
considering the loss of cone in the rd1 retina, the results
obtained were quite similar for both methods. The only
noticeable difference was observed at PN35 with a reduc-
tion of the cone density of 49% (Figure 2b) versus 31%
(Figure 2c), which does not result from a bias in the sam-
pling since the equivalent results were obtained after hav-
ing reversed the polarity of the eyes (Additional file 3).
We also developed an automated stereological counting
method based on smaller fields (218 × 173 pixels) distribu-
ted over the surface of the retina. We expected that the
automated identification of cones from these reduced fields
would be facilitating the recognition of cones by the soft-
ware (Figure 3a). When this method was applied to the
images used in figure 2b, similar results were observed with
a reduction of 50% of the cone density between PN15 and
35 for the rd1 retinas, while the overall densities were
slightly reduced (Figure 3b, Additional file 3). The loss of
cones between PN15 and 35 in the rd1 retinas seems to be
distinct for both automated methods when compared to
stereology (Figure 4a). However, when the data were nor-
malized using the quantile-quantile method [16] the counts
look very similar, yielding a two-way ANOVA value of 1
indicating that the difference most likely results from a sys-
tematic offset (Figure 4b and Additional file 4). This indi-
cates that the two automated methods measure the cone
density with equivalent accuracy as the more tedious
stereological one.
Spatiotemporal loss of cones degeneration in the rd1
mouse
The global automated counting method on oriented flat-
mounted retina provides the opportunity to study the
spatial distribution of the cones. We explored this
potential by measuring the S-cone densities in the rd7
retina. The rd7 mouse carries a recessive mutation in
the orphan nuclear receptor Nr2e3 causing a develop-
mental defect that results in an excess of S-cones [18].
The S-cones were labeled with anti S-opsin polyclonal
antibodies (Figure 5a). The excess of S-cones are loca-
lized in the ventral part of the rd7 retina (Figure 5d and
5b), when compared to the wild-type on a C3HfHeA
(Figure 5e and 5c), and on a C57BL/6@N background
(Additional file 5). This excess of S-cones was also
observed on flat-mounted rd7 retinas and similarly loca-
lized to the ventral part of the retinal explant (Figure 5i
and 5g), however there is no apparent difference in the
total number of cones, labeled with PNA (Figure 5h and
5f). After global automated counting, we reconstituted
the density of S-cones on a virtual eye fundus of the rd7
mouse in order to facilitate the visualization of the
results (see Methods). In this representation, S-cones
are concentrated in the ventral region of the rd7 retina
(Figure 5j).
We next used this representation to visualize the spa-
tiotemporal loss of cones in the rd1 retinas. The virtual
eye fundus was obtained by averaging 7 retinas. For the
wild-type mouse, an evenly distributed increase in cones
was observed between PN15 and 35 accordingly to fig-
ure 2B, there-after no major change occurs (Figure 6a).
The distribution of cones in the rd1 retina at PN15 is
rather similar to the wt retinas at PN35. However, from
PN15 to 90 a decrease of cones at the centre of the
retina is observed. This is consistent with the centro-
peripheral degeneration of cones as reported previously
for rd1 [19-21], however it does not necessarily imply
that the cones degenerate at a higher rate in the centre
of the retina in a model of rod-cone interaction [22]. In
order to address this question we plotted the average
density of cones in the rd1 retina in concentric circles
from the centre of the retina (Figure 6b). As seen on the
graph, the loss of cone at each position relative to the
centre is similar between PN15 to 45. Because the den-
s i t yo fc o n e si sh i g h e ri nt h ep e r i p h e r ya tP N 1 5( F i g u r e
6c), the centro-peripheral pattern observed in figure 6a
is created by the the centro-peripheral density of cones
at start. This early phase correlates with the death of
cones resulting presumably from the loss of expression
of diffusible trophic molecules produced by rods [4,10].
We observed at latter stages, from PN35 that the cones
degenerate at a slower pace. This means that at least
two events are involved in the degeration of cones. The
protective effect generate by antioxidant molecules [23]
indicates that oxidative stress may be one of the triggers.
RdCVF, the thioredoxin-like protein would be limiting
oxidative damage that would be higher when rod die
between PN15 and 35. From PN35 to 60 the two rows
of cone at the periphery are retarded as compared to
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Page 6 of 15Figure 2 Validation of the automated counting method. (a) Staining of cones with PNA in wild-type (wt) and in retinal degeneration (rd1)o f
flat-mounted retina at PN15, 35 and 90. (b) Average cone densities of rd1 and wt retinas using global automated counting method. (c) Average
cone densities of rd1 and wt retinas using stereological counting on contralateral eyes. The data represents an average of at least seven retinas
per age and per genotype. Error bars show +/- SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bar: 100 μm.
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Page 7 of 15Figure 3 Automated stereological counting method. (a) A counted area showing the cones. The number of cones after exclusion and before
exclusion (in brackets) is mentioned below the image. Cones in contact with the two coordinates (white lines) are automatically excluded. The
colored dots represent the increment of the counting process. The colored circle point to excluded objects following the counting parameters
(Spotcutoff, Spotsize and SurfSpot, Additional file 4) and counting window. More specifically, from the top to the bottom, the circles mean:
Yellow, not satisfying the counting parameters; Black, cross the Y exclusion axe; Red, not satisfying the parameters and Purple, not satisfying the
counting parameters. (b) Average cone densities of rd1 and wt retinas using automated stereological counting (n = 7). Error bars show +/- SEM,
* p < 0.05, ** p < 0.01, *** p < 0.001.
Clérin et al. BMC Ophthalmology 2011, 11:38
http://www.biomedcentral.com/1471-2415/11/38
Page 8 of 15Figure 4 Comparison of the three methods of counting. (a) Average cone density before normalization for the three methods used
(stereological, global automated and automated stereological method). A two-way ANOVA with one factor representing days and the second
factor the method, shows a difference with a p-value equal to 6.42 10
9. (b) Average cone density after normalization for the three methods
used. The normalization involved use of the quantile-quantile method so that the quantiles of the set of measures obtained by each technique
are equal. This normalization revealed a p-value of 1 indicating the absence of difference between the three methods.
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Page 9 of 15more central cones in agreement with earlier observa-
tions on persistence of cones in the periphery of rd1
retinas [19].
Pattern of cone degeneration in the mouse lacking the
nucleoredoxin-like genes
Since the secondary degeneration of cones results at
least partly from the loss of expression of the Rod-
derived Cone Viability Factors [8], we examined the spa-
tiotemporal pattern of the cones in mice lacking either
the nucleoredoxin-like 1 or 2, genes (Nxnl1 and Nxnl2,
respectively). We have reported a reduction of 17% in
cone number in the Nxnl1-/- mouse at 15 weeks of age
[9]. Here we reported the progression of this degenera-
tive process with a 30% reduction of cones at 8 months
(Figure 7a). We also investigated the density of cones in
Figure 5 Regionalization of S-cones in rd7 retina. (a) Staining of PNA (red), S-Opsin (green) and nuclei (blue) on a section of rd7 retina at
PN35 (Scale bar: 100 μm). (d, b) Higher expression of S-opsin ventrally than dorsally at higher magnification. (e, c) The difference of expression
of S-Opsin expression in wild type (C3HfHeA) at high magnification. Staining of PNA (f, h) and S-Opsin (g, i) in rd7 flat-mounted retina at PN35.
Scale bar: 25 μm for b-i. (j) Virtual eye fundus representing the S-cone density in the rd7 retina in 9 rows from the centre (optic nerve). The
density of S-cones in each segment is encoded by a color scale. Excluded areas are represented by a grey color and the absolute cone density
value from dark blue, yellow to dark red are: 45, 90, 135, 180, 225, 270, 315, 360 and 405 cones/surface unit.
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Page 10 of 15the Nxnl2-/- mouse, the gene encoding the paralogue
RdCVF2 [10] (Jaillard et al., manuscript in preparation).
At 8 months of age the cone density was found to be
34% reduced as compared to controls on identical
genetic background. The distribution pattern of this
decrease in cone density is not homogenous, with an
apparent higher deficit in the ventral region of the
Nxnl2-/- retina, compared to the Nxnl1-/- mouse (n =
Figure 6 Spatio-temporal quantification of cones of rd1 flat retina during cones degeneration. (a) Virtual eye fundus representing the
cone density measured by global automatic counting of cones labeled with PNA on flat-mounted wild-type and rd1 retinas from PN15 to PN90
(D: dorsal, V: ventral, T: temporal, N: nasal). The density of cones in each segment is encoded by a color scale and the absolute cone density
value from dark blue, yellow to dark red are: 45, 90, 135, 180, 225, 270, 315, 360 and 405 cones/surface unit. (b) Average density of cones
(cones/0.0376 mm
2)i nrd1 retina for the 9 rows centered on the optic nerve (peripheral to central) from PN15 to PN90. (c) PNA staining cones
in rd1 flat-mounted retina at PN15 in central area of the retina (left) and peripheral area retina (right).
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Page 11 of 15Figure 7 Loss of cones in the Nxnl1-/- and Nxnl2-/- retinas its regionalization. (a) Global automated counting of cones of Nxnl1-/- and
Nxnl2-/- versus Nxnl+/+ at PN8 months, (n = 7, 8, 10 respectively). Error bars show +/- SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (b)
Visualization using virtual eye fundus of the cone density for the three genotypes. The density of cones in each segment is encoded by a color
scale. Excluded areas are represented by a grey color and the absolute cone density value from dark blue, yellow to dark red are: 45, 90, 135,
180, 225, 270, 315, 360 and 405 cones/surface unit. (c) Regionalization of the cone density in the ventral versus the dorsal region of the retina.
The surface of the regions (2.48 mm
2) represents 22% of the retina. Error bars show +/- SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. (d) S-cone
density on the Nxnl+/+ and Nxnl2-/- retinas. (e) Regionalization of the S-cone density in the ventral versus the dorsal region of the Nxnl+/+ and
Nxnl2-/- retinas.
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Page 12 of 157-10, Figure 7b). In order to quantify this regional effect
we compared the density of cones in 66 fields (2.48
mm
2) at ventral and dorsal locations (Figure 7c). The
dorsal and ventral fields are equidistant from the optic
nerve. The respective 66 fields represent 6 rows and 11
columns centered on the dorso-ventral axis. The dorsal
fields are separated from the ventral fields by a two
rows (335.4 μm). This analysis shows that there is a sta-
tistical difference in the deficit of the ventral versus the
dorsal region of the retina for the Nxnl2-/- mouse, sug-
gesting that the two paralogous genes are part of a
slightly distinct endogenous neuroprotective signaling
pathways. We have observed similar deficit in the S-
cone density in the Nxnl2-/- retina compared to its con-
trol (n = 5, Figure 7d). The analysis of the regionaliza-
tion shows that the S-cone are affected to the same
extend in the dorsal and in the ventral region of the
Nxnl2-/- retina (Figure 7e), demonstrating that both the
M and the S-cones are affected by the disruption of the
Nxnl2 gene.
Discussion
We demonstrated the usefulness of ℮-conome, a novel
automated platform to quantify cone survival in mouse
models of retinal degeneration. This technology will
greatly accelerate the transition form bench to clinic for
therapeutic agents such as Rod derived Cone Viability
Factors that are aimed at preventing vision loss in
patients suffering from retinitis pigmentosa. The robust-
ness of the platform relies on the segmentation of the
flat-mounted retina into ~300 fields in which 9 z-planes
are acquired from the best focus determined individually
form each field. The treatment of each of these 9 images
involved filtering steps which include a morphological
filter and the identification of each object (cones) using
parameters whose values have been empirically set-up.
The trophic effects of RdCVF proteins formulated for
clinical trial or of AAV-RdCVF [7,12] can now be quan-
tified in a less time-consuming manner that avoids
human bias, thus facilitating dose-response studies. This
platform is essential for the transfer of this promising
therapeutic approach into clinical practice. It also per-
mits the measurement of local effects as demonstrated
by the reduction of the cone density in the ventral part
of the retina of the Nxnl2-/- mouse. This is important
considering the desired diffusion of the trophic effect
from the site of injection. It is interesting to notice that
such gradient of cone degeneration was also observed in
a mouse with a specific inactivation in cones of the reg-
ulatory subunit p85 alpha of PI3Kinase [24]. We also
demonstrate that this method can be efficiently applied
to other markers in addition to the lectin PNA. The
polyclonal anti-S-opsin antibodies were used to quantify
the excess of S-cones in the ventral part of the rd7
mouse model. The platform is also a tool to study the
signaling between rods and cones [9]. It could also be
used to quantify the up-regulation of HIF1A and
GLUT1 in cones that is observed following rod degen-
eration [25].
The quantification of neuron survival and neuropatho-
logical lesions in neurodegenerating tissues is essential
for the development of therapeutic strategies relying on
the delivery of trophic factors [26]. With regard to other
retinal diseases, ℮-conome was used to count retinal
Brn3a-labeled cells ganglion cells by placing this cell
layer in the direction of the objective and by recalculated
the eleven parameters used (results not shown). In the
brain, the automated stereological method developed to
count cone photoreceptors could be applied to quantify
ischemic brain injury using histological sections labeled
to track apoptosis using terminal UTP nick end labeling
(TUNEL). It should be noted that the high-throughput
method developed for the quantification of neurofibril-
lary tangles and senile plaques found in the brains of
patients affected by Alzheimer’s disease involves a man-
ual step of focusing the images which significantly slows
the process [27], compared to the method used here.
Conclusions
In summary, e-conome provided an accurate platform to
measure the density of the cones. In addition we show
that the spatiotemporal pattern of cone loss in the
Nxnl2-/- retina proceeds from the ventral part. The
automated platform used here for retinal disease could
accelerate translational research for neurodegenerative
diseases more broadly.
Additional material
Additional file 1: ℮-CONOME journals. (a) ACQUISITION.JNL. (b)
COUNTING.JNL. Bold words correspond to recorded journals. All the
numbered lanes designate building functions use by the journals. Italic
words indicate assigned variables of the journals. Green words in italic
are not used in the ℮-CONOME application.
Additional file 2: Illustration of the image processing: (a) before
processing. (b) after processing. The yellow squares indicate the
cones. The parameters for counting are indicated in green.
Additional file 3: Counting of cones. (a) Stereological method: serial 1.
(b) Stereological method: serial 2. (c) Global automated method: serial 1.
(d) Global automated method: serial 2. (e) Automated stereological
method.
Additional file 4: Comparison of the three methods of counting
before normalization (BN) and after (AN). (a) Stereological method.
(b) Global automated method. (C) Automated stereological method.
Additional file 5: Sections of the C57BL/6@N retina at PN 35 after
labeling with S-opsin antibodies (green). PNA, red, DAPI, blue. (a)
dorsal. (b) ventral. Notice that labeling was made with a different aliquot
of the S-opsin antibodies as compared to figure 6. Scale bar 25 μm.
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BSA: Bovine serum albumin; DMEM: Dulbecco’s Modified Eagle Medium;
NGS: Normal goat serum; Nxnl1: Nucleoredoxin-like 1 gene; Nxnl2:
Nucleoredoxin-like 2 gene; PBS: Phosphate-buffered saline; PFA:
Paraformaldehyde; PN: Post-Natal day; PNA: Peanut agglutinin lectin from
arachis hypogae; RdCVF: Rod-derived Cone Viability factor; TUNEL: Terminal
UTP nick end labeling
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